STAT5B and prostate cancer: Whatever the mechanisms driving the intrinsic decline of prostatic STAT5 signaling in Pb-PRL mice, the various genotype- and age-related phenomena observed in our study may shed light on possible outcomes of long-term pharmacological inhibition of STAT5 in prostate cancer context.